Cellular pharmacology of antisense oligodeoxynucleotides.
Schumacher
C
C
Novartis Pharmaceuticals Corporation, Summit, New Jersey 07901-1398, USA.
D001158:Arteries / Q000166:cytology / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D015870:Gene Expression / Q000187:drug effects; D006207:Half-Life; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology*; D019908:Proto-Oncogene Proteins c-raf / Q000096:biosynthesis* / Q000235:genetics; D013873:Thionucleotides / Q000494:pharmacology*
D020319:Oligodeoxyribonucleotides, Antisense; D013873:Thionucleotides; C099587:ISIS 5132; D019908:Proto-Oncogene Proteins c-raf